Chattem Chemicals Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is AMPHETAMINE ASPARTATE MONOHYDRATE, with a corresponding US DMF Number 37626.
Remarkably, this DMF maintains an Active status since its submission on June 28, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 10, 2024, and payment made on July 17, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II